Aviram J

ORCID: 0000-0003-2075-5446 · 3 papers in corpus
2025
Medical cannabis in Israel: a comprehensive review of trends and regulations, 2011-2025.
Journal of cannabis research ·doi:10.1186/s42238-025-00344-1

BACKGROUND: Since its initial approval in 1992, medical cannabis (MC) in Israel has undergone extensive regulatory and structural transformation. This study aims to present the most comprehensive retrospective analysis to date of the evolvi…

2023
Evaluating Sex Differences in Efficacy, Safety and Pharmacokinetics in Patients Treated with Cannabis by a Metered-Dose Inhaler.
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph16101426

BackgroundClinical studies on medical cannabis (MC) treatment have shown sex-related differences, including higher susceptibility to adverse events among women and greater analgesia among men. Here, we used the Syqe metered-dose inhaler (MD…

2020
Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients.
Rambam Maimonides medical journal ·doi:10.5041/rmmj.10384

ObjectiveThe aim of this cross-sectional questionnaire-based study was to identify associations between the doses of cannabinoids and terpenes administered, and symptoms of attention deficit hyperactivity disorder (ADHD).MethodsParticipants…